New Delhi [India], February 10: Genomics is not just about treating disease after it appears. It is about personalising wellness plans, optimising drug choices, and enabling population screening that prevents illness and reduces the long-term cost of care. As Dr. Shrinidhi Nathany, Consultan
Washington [US], October 6 (ANI): Researchers at MIT and Dana-Farber Cancer Institute have developed a new way to determine whether individual patients will respond to a specific cancer drug or not. This kind of test could help doctors to choose alternative therapies for patients who don't r